Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI (ETAMI)

This study has been completed.
Sponsor:
Collaborator:
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
Stiftung Institut fuer Herzinfarktforschung
ClinicalTrials.gov Identifier:
NCT01327534
First received: March 29, 2011
Last updated: June 15, 2016
Last verified: June 2016